ЛИТЕРАТУРА/REFERENCES
1. PLeines U.E., Morganti-Kossmann M.C., Rancan M., et aL. S-100 beta reflects the extent of injury and outcome, whereas neuronaL specific enoLase is a better indicator of neuroinfLammation in patients with severe traumatic brain injury. J Neurotrauma. 2001; 18: 491-8.
2. Woertgen C., RothoerL R.D., Metz C., Brawanski A. Comparison of cLinicaL, radioLogic, and serum marker as prognostic factors after severe head injury. J Trauma. 1999; 47: 1126-30.
3. Hayakata T., Shiozaki T., Tasaki O., et aL. Changes in CSF S100B and cytokine concentrations in earLy-phase severe traumatic brain injury. Shock. 2004; 22: 102-7.
4. Foerch C., Singer O.C., Neumann-HaefeLin T., et aL. EvaLuation of serum S100B as a surrogate marker for Long-term outcome and infarct voLume in acute middLe cerebraL artery infarction. Arch NeuroL. 2005; 62: 1130-4.
5. Sanchez-Pena P., Pereira A.R., Sourour N.A., et aL. S100B as an additionaL prognostic marker in subarachnoid aneurysmaL hemorrhage. Crit Care Med 2008; 36: 2267-73.
6. Kovesdi E., LuckL J., Bukovics P., et aL. Up-date on protein biomarkers in traumatic brain injury with emphasis on cLinicaL use in aduLts and pediatrics. Acta Neurochir (Wien). 2010; 152: 1-17.
7. Moritz S., Schmidt C., Bucher M., et aL. Neuromonitoring in carotid surgery: are the resuLts obtained in awake patients transferabLe to patients under sevofLurane/fentanyL anesthesia? J Neurosurg AnesthesioL. 2010; 22: 21-31.
8. Risso F.M., Sannia A., GazzoLo D. Preterm and term newborn: primary investigations. J Matern FetaL NeonataL Med. 2012; 25: 70-2.
9. HeLLstrom-Westas L., Rosen I. Continuous brain-function monitoring: state of the art in cLinicaL practice. Semin FetaL NeonataL Med. 2006; 11: 503-11.
10. Kochanek P.M., Berger R.P., Bayir H., et aL. Biomarkers of primary and evoLving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care. 2008; 14: 135-41.
11. GazzoLo D., AbeLLa R., FrigioLa A., et aL. Neuromarkers and unconventionaL bioLogicaL fluids. J Matern FetaL NeonataL Med. 2010; 23: 66-9.
12. GazzoLo D., AbeLLa R., Marinoni E., et aL. New markers of neonataL neuroLogy. J Matern FetaL NeonataL Med. 2009; 22: 57-61.
13. FLorio P., AbeLLa R., Marinoni E., et aL. BiochemicaL markers of perinataL brain damage. Front Biosci (SchoL Ed). 2010; 2: 47-72.
14. GazzoLo D., Di Iorio R., Marinoni E., et aL. S100B protein is increased in asphyxiated term infants deveLoping intraventricuLar hemorrhage. Crit Care Med. 2002; 30: 1356-60.
15. Risso F.M., Serpero L.D., Zimmermann L.J., et aL. PerinataL asphyxia: kidney faiLure does not affect S100B urine concentrations. CLin Chim Acta. 2012; 18: 150-3.
16. GazzoLo D., Marinoni E., Di Iorio R., et aL. Measurement of urinary S100B protein concentrations for the earLy identification of brain damage in asphyxiated fuLL-term infants. Arch Pediatr AdoLesc Med. 2003; 157: 1163-8.
17. CuLLen V.C., Fredenburg R.A., Evans C., et aL. DeveLopment and advanced vaLidation of an optimized method for the quantitation ofAb42 in human cerebrospinaL fLuid. AAPS J. 2012; 14: 510-8.
18. Koo J., Byun Y. Current status of PET-imaging probes of beta-amyloid plaques. Arch Pharm Res 2013; 36 (10): 1178-84.
19. Apple F.S., Jesse R.L., Newby L.K., et al. National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation. 2007; 115: e352-5.
20. Mulligan J.C., Painter M.J., O'Donoghue P.A., et al. Neonatal asphyxia II. Neonatal mortality and long-term sequelae. J Pediatr. 1980; 96: 903-7.
21. Low J.A., Lindsay B.G., Derrick E.J. Threshold of metabolic acidosis-associated with newborn complications. Am J Obstet Gynecol. 1997; 177: 1391-4.
22. Gazzolo D., Michetti F. Perinatal S100B protein assessment inhuman unconventional biological fluids: a minireview and new perspectives. Cardiovasc Psychiatry Neurol. 2010; 2010: 703563.
23. Ferri G.L., Probert L., Cocchia D., et al. Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system. Nature. 1986; 297: 409-10.
24. Pham N., Fazio V., Cucullo L., et al. Extracranial sources of S100B do not affect serum levels. PLoS One. 2010; 5 (9).
25. Blennow M., Savman K., Ilves P., et al. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr. 2001; 90: 1171-5.
26. Gazzolo D., Bruschettini M., Corvino V., et al. S100b protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. Clin Chem. 2001; 47: 954-6.
27. Gazzolo D., Bruschettini M., Lituania M., et al. S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. Clin Chem. 2001; 47: 1132-3.
28. Gazzolo D., Vinesi P., Marinoni E., et al. S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem. 2000; 46: 998-1000.
29. Gazzolo D., Kornacka M., Bruschettini M., et al. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem. 2003; 4: 1215-8.
30. Sannia A., Risso F.M., Serpero L.D., et al. Antenatal glucocorticoid treatment affects preterm infants' S100B urine concentration in adosedependent manner. Clin Chim Acta. 2010; 411: 1539-41.
31. Gazzolo D., Florio P., Ciotti S., et al. S100B protein in urine of preterm newborns with ominous outcome. Pediatr Res. 2005; 58: 1170-4.
32. Gazzolo D., Frigiola A., Bashir M., et al. Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS One. 2009; 4: e4298.
33. Florio P., Gazzolo D., Luisi S., et al. Activin A in brain injury. Adv Clin Chem. 2007; 43: 117-33.
34. Florio P., Luisi S., Bruschettini M., et al. Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem. 2004; 50: 2386-9.
35. Florio P., Frigiola A., Battista R., et al. Activin A in asphyxiated full term newborns with hypoxic ischemic encephalopathy. Front Biosci (Elite Ed). 2010; 2: 36-42.
36. Florio P., Luisi S., Moataza B., et al. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin Chem. 2007; 53: 520-2.
37. Sannia A., Zimmermann L.J., Gavilanes A.W., et al. Elevated activin A urine levels are predictors of intraventricular hemorrhage in preterm newborns. Acta Paediatr. 2013; 102 (10). doi: 10.1111/apa.12332.
38. Florio P., Perrone S., Luisi S., et al. Increased plasma concentrations of activin A predict intraventricular hemorrhage in preterm newborns. Clin Chem. 2006; 52: 1516-21.
39. Bellissima V., Ververs T.F., Visser G.H., Gazzolo D. Selective serotonin reuptake inhibitors in pregnancy. Curr Med Chem. 2012; 19: 4554-61.
40. Bellissima V., Visser G.H., Ververs T.F., et al. Antenatal maternal antidepressants drugs affect activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood. J Matern Fetal Neonatal Med. 2011; 24: 31-4.
41. Di Iorio R., Marinoni E., Lituania M., et al. Adrenomedullinin creases in term asphyxiated newborns developing intraventricular hemorrhage. Clin Biochem. 2004; 37: 1112-6.
42. Di Iorio R., Marinoni E., Letizia C., et al. Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms. Am J Obstet Gynecol. 2000; 182: 650-4.
43. Gazzolo D., Marinoni E., Giovannini L., et al. Circulating adrenomedullin is increased in preterm newborns developing intraventricular hemorrhage. Pediatr Res. 2001; 50: 544-7.
44. Florio P., Luisi S., Bruschettini S., et al. Cerebrospinal fluid activin A measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem. 2004; 50: 2386-9.
45. Florio P., Reis F., Severi F., et al. Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the utero-placental and fetal circulation. Placenta. 2006; 27: 432-7.
46. Florio P., Frigiola A., Battista R., et al. Activin A in asphyxiated full-term newborns with hypoxic ischemic encephalopathy. Front. Biosci. 2010; 2: 36-42.
47. Di Iorio R., Marinoni E., Gazzolo D., et al. Maternal nitric oxide supplementation increases adrenomedullin concentrations ingrowth retarded fetuses. Gynecol Endocrinol. 2002; 16: 187-92.
48. Florio P., Abella R., Marinoni E., et al. Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Clin Chem. 2008; 54: 202-6.
49. Pahlman S., Esscher T., Bergvall P., Odelstad L. Purification and characterization of human neuron-specific enolase: radioimmunoassay development. Tumour Biol. 1984; 5: 127-39.
50. Basile A.M., Fusi C., Conti A.A., et al. S-100 protein and neuron specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-month follow-up study. Eur Neurol. 2001; 45: 151-9.
51. Fogel W., Krieger D., Veith M., et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med. 1997; 25: 1133-8.
52. Garcia-Alix A., Cabanas F., Pellicer A., et al. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants. Pediatrics. 1994; 93: 234-40.
53. Celtik C., Acunas B., Oner E., et al. Neuron-specific enolase as a marker of the severity and outcome of hypoxic encephalopathy. Brain Dev. 2004; 26: 398-402.
54. Nagdyman N., Komen W., Ko H., et al. Early biochemical indicators of hypoxic ischemic encephalopathy after birth asphyxia. Pediatr Res. 2001; 49: 502-6.
55. Roka A., Kelen D., Halasz J., et al. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr. 2012; 101: 1184-8.
56. Bracci R., Perrone S., Buonocore G. The timing of neonatal brain damage. Biol Neonate. 2006; 90: 145-55.
57. Perrone S., Tataranno M.L., Stazzoni G., Buonocore G. Biomarkers of oxidative stress in fetal and neonatal diseases. J Matern Fetal Neonatal Med. 2012; 25: 2575-8.
58. Perrone S., Tataranno M.L., Stazzoni G., et al. Oxidative injury in neonatal erythrocytes. J Matern Fetal Neonatal Med. 2012; 25: 104-8.
59. Blennow M., Rosengren L., Jonsson S., et al. Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings. Acta Paediatr. 1996; 85: 485-9.
60. Ennen C.S., Huisman T.A., Savage W.J., et al. Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathytreated with whole-body cooling. Am J Obstet Gynecol. 2011; 205: 251-7.
61. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 1968; 61: 748-55.
62. Denschlag D., Marculescu R., Unfried G., et al. The size of a micro-satellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod. 2004; 10: 211-4.
63. Bainbridge S.A., Smith G.N. HO in pregnancy. Free Radic Biol Med. 2005; 38: 979-88.
64. Shrestha Dangol D., Chen H.P. Role of hemeoxygenase-2 in pregnancy-induced hypertension. Int J Gynaecol Obstet. 2004; 85: 44-6.
65. Barber A., Robson S.C., Myatt L., et al. Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB J. 2001; 15: 1158-68.
66. Eide I.P., Isaksen C.V., Salvesen K.A., et al. Decidual expression and maternal serum levels of heme oxygenase 1 are increased in preeclampsia. Acta Obstet Gynecol Scand. 2008; 87: 272-9.
67. Tanaka Y., Maher J.M., Chen C., Klaassen C.D. Hepatic ischemia reperfusion induces renal heme oxygenase-1 via NF-E2-relatedfactor 2 in rats and mice. Mol Pharmacol. 2007; 71: 817-25.
68. Fujita T., Toda K., Karimova A., et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med. 2001; 7: 598-604.
69. Li Volti G., Galvano F., Frigiola A., et al. Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach. J Nutr Biochem. 2010; 21: 865-71.
70. Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001; 107: 823-6.
71. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
72. Looney A.-M., et al. Down-regulation of umbilical cord blood levels of miR-374a in neonatal hypoxic ischemic encephalopathy. J. Pediatr. 2015; 167: 269-73.
73. Whitehead C., et al. Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status. BMC Med. 2013, 11: 256.
74. Sannia A., Risso F.M., Zimmermann L.J., et al. S100B urine concentrations in late preterm infants are gestational age and gender dependent. Clin Chim Acta. 2013; 417: 31-4.
75. Serpero L.D., et al. J Matern Fetal Neonatal Med. 2013; 26 (S2): 44-9. Downloaded by [Federal State Institution] at 04:02 11 July 2016.
76. Risso F.M., Serpero L.D., Zimmermann L.J., et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr. 2013; 102 (10): e467.
77. Florio P., Marinoni E., Di Iorio R., et al. Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics. 2006; 118: e747-54.
78. Florio P., Michetti F., Bruschettini M., et al. Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death. Lancet. 2004; 364: 270-2.
79. Gazzolo D., Serpero L.D., Frigiola A., et al. Antenatal glucocorticoids supplementation and central nervous system development. Curr Drug Metab. 2013; 14: 160-6.
80. Risso F.M., Sannia A., Gavilanes D.A., et al. Biomarkers of brain damage in preterm infants. J Matern Fetal Neonatal Med. 2012; 25: 101-4.
81. Michetti F., Corvino V., Geloso M.C., et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem. 2012; 120: 644-59.
82. Atzori L., Antonucci R., Barberini L., et al. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed). 2011; 3: 1005-12.
83. Dessi A., Atzori L., Noto A., et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med. 2011; 24: 35-9.
84. Roka A., Kelen D., Halasz J., et al. Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr. 2012; 101: 319-23.